PTGS2 and hepatocellular carcinoma: The data demonstrated that compared with low expression of COX-2 or HIF-1α, the overall survival in HCC patients with high expression of COX-2 or HIF-1α has a downward trend (P = 0.002 and P = 0.007, respectively, Figure 1(b)).